Green tea ingredient may ameliorate memory impairment, brain insulin resistance, and obesity

Green tea ingredient may ameliorate memory impairment, brain insulin resistance, and obesity A new study involving mice, suggests that EGCG (epigallocatechin-3-gallate), the most abundant catechin and biologically active component in green tea, could alleviate high-fat and high-fructose (HFFD)-induced insulin resistance and cognitive impairment. Green tea ingredient may ameliorate memory impairment, brain insulin resistance, and obesity …

Details

Concerns that sleep apnea could impact healthspan

Concerns that sleep apnea could impact healthspan The number of people with obstructive sleep apnea has steadily increased over the past two decades. Obesity and advanced age, which have been reported as risk factors, are also on the rise. Scientists are concerned because sleep apnea may diminish healthspan by aggravating several cardiovascular and neurodegenerative diseases. …

Details

Novel perspectives on anti-amyloid treatment for the prevention of Alzheimer's disease

Novel perspectives on anti-amyloid treatment for the prevention of Alzheimer’s disease For decades, researches have been investigating the underlying foundations of Alzheimer’s disease to provide clues for the design of a successful therapy. Breakthrough insights reveal the molecular basis of the hereditary form of Alzheimer’s disease that strikes early in life. Novel perspectives on anti-amyloid…

Details

Increased risk of dementia in patients who experience delirium after surgery

Increased risk of dementia in patients who experience delirium after surgery Delirium is common in elderly hospitalized patients, affecting an estimated 14-56 percent of patients. It frequently manifests as a sudden change in behavior, with patients suffering acute confusion, inattention, disorganized thinking and fluctuating mental status. Increased risk of dementia in patients who experience delirium…

Details

Newly discovered biomarkers may lead to promising diagnostic tool for Alzheimer's

Newly discovered biomarkers may lead to promising diagnostic tool for Alzheimer’s Diagnosing Alzheimer’s disease and determining a patient’s prognosis is an inexact business, and that stands in the way of better personalized care and advances in treatment. A new study has identified a potential new way of confirming the disease and predicting a patient’s outlook. …

Details